Bortezomib to treat the TEMPI syndrome

N Engl J Med. 2012 May 10;366(19):1843-5. doi: 10.1056/NEJMc1202649.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Intramural

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Erythropoietin / blood
  • Female
  • Humans
  • Lymphangiectasis
  • Middle Aged
  • Paraproteinemias / drug therapy*
  • Polycythemia / drug therapy*
  • Pyrazines / therapeutic use*
  • Syndrome
  • Telangiectasis / drug therapy*

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Erythropoietin
  • Bortezomib